-transparent.png){kind=logo}
The effect of 5-aza-2'-deoxycytidine (5-AZA-dCyd) on methylation of DNA in blood leukemic cells from patients with lymphoid and myeloid leukemia was investigated. After treatment with continuous infusion of 5-AZA-dCyd (1.0 mg/kg/h) the blood leukemic cells were isolated and incubated in vitro with [6-3H]deoxycytidine and the incorporation of radioactivity into 5-methylcytosine and cytosine of DNA determined. 5-AZA-dCyd produced greater than 70% inhibition of DNA methylation in the leukemic cells. The antileukemic action of 5-AZA-dCyd may be related to the inhibition of DNA methylation.
Related Publications
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
May 2006,
Cancer research,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
May 1993,
Leukemia,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
January 1985,
Pharmacology & therapeutics,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
January 2014,
Clinical epigenetics,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
August 2003,
Cancer,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
January 1981,
Leukemia research,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
October 1984,
Molecular and cellular biology,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
August 2004,
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
December 2014,
Endocrinology,
R L Momparler, and
J Bouchard, and
N Onetto, and
G E Rivard
June 2019,
Reproductive sciences (Thousand Oaks, Calif.),
